Fermenta Biotech adds plant-based Vitamin D3 capacity at Dahej
Fermenta Biotech is investing ₹110 crore to expand plant-based Vitamin D3 and derivatives production in Dahej, targeting supplement, nutraceutical, fortified-food and beverage brands seeking vegetarian, clean-label inputs. Commercial production is expected in FY28.
Fermenta Biotech is investing ₹110 crore to expand plant-based Vitamin D3 and derivative production at Dahej, targeting Indian supplement, nutraceutical, fortified-food and beverage brands seeking vegetarian, clean-label alternatives to animal-derived Vitamin D3.
Why this matters
No related recent Fermenta Biotech signals are listed; the Dahej project is the available indicator of its move into plant-based Vitamin D3 capacity.
Retail-company signals are accelerating, up 390467% QoQ.